Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate in osteoporosis with chronic kidney disease stage 3a-3b
IRCT20180506039549N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Alendronate with Placebo (2 arms). Primary endpoint: Bone density. Started Oct 2017; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on IRCT20180506039549N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180506039549N1.